Docusign (NASDAQ:DOCU – Free Report) had its price target reduced by UBS Group from $75.00 to $54.00 in a research report sent to investors on Wednesday morning,Benzinga reports. UBS Group currently has a neutral rating on the stock.
A number of other research analysts also recently issued reports on the stock. Citigroup restated a “market outperform” rating on shares of Docusign in a research report on Monday, March 2nd. HSBC set a $53.00 price objective on shares of Docusign in a research note on Friday, February 13th. JPMorgan Chase & Co. cut their target price on shares of Docusign from $80.00 to $78.00 and set a “neutral” rating on the stock in a report on Friday, December 5th. Citizens Jmp decreased their target price on Docusign from $124.00 to $86.00 and set a “market outperform” rating for the company in a research note on Wednesday. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Docusign in a research report on Tuesday, March 10th. Five analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $66.67.
Read Our Latest Stock Report on Docusign
Docusign Trading Down 1.1%
Docusign (NASDAQ:DOCU – Get Free Report) last announced its quarterly earnings data on Tuesday, March 17th. The company reported $1.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.95 by $0.06. Docusign had a return on equity of 16.86% and a net margin of 9.60%.The firm had revenue of $836.86 million for the quarter, compared to analysts’ expectations of $828.23 million. During the same period last year, the business posted $0.86 earnings per share. The firm’s revenue for the quarter was up 7.8% on a year-over-year basis. As a group, equities analysts predict that Docusign will post 1.17 earnings per share for the current year.
Docusign announced that its board has approved a stock buyback program on Tuesday, March 17th that allows the company to repurchase $2.00 billion in shares. This repurchase authorization allows the company to purchase up to 21% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company’s leadership believes its stock is undervalued.
Insider Buying and Selling at Docusign
In other news, CRO Paula Hansen sold 6,000 shares of Docusign stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $67.05, for a total value of $402,300.00. Following the transaction, the executive owned 68,970 shares of the company’s stock, valued at $4,624,438.50. This trade represents a 8.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider James P. Shaughnessy sold 12,000 shares of the business’s stock in a transaction on Friday, January 2nd. The stock was sold at an average price of $67.03, for a total transaction of $804,360.00. Following the completion of the sale, the insider owned 54,550 shares of the company’s stock, valued at $3,656,486.50. The trade was a 18.03% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 68,173 shares of company stock worth $4,324,684 in the last ninety days. Company insiders own 1.01% of the company’s stock.
Institutional Inflows and Outflows
Several institutional investors have recently bought and sold shares of DOCU. Vanguard Group Inc. lifted its position in Docusign by 1.1% during the 3rd quarter. Vanguard Group Inc. now owns 21,625,551 shares of the company’s stock worth $1,558,986,000 after acquiring an additional 225,525 shares during the last quarter. State Street Corp grew its position in shares of Docusign by 0.9% in the fourth quarter. State Street Corp now owns 8,193,805 shares of the company’s stock valued at $560,456,000 after purchasing an additional 77,008 shares during the last quarter. Capital World Investors grew its position in shares of Docusign by 38.1% in the fourth quarter. Capital World Investors now owns 5,815,804 shares of the company’s stock valued at $397,801,000 after purchasing an additional 1,603,900 shares during the last quarter. American Century Companies Inc. increased its stake in shares of Docusign by 1.6% in the second quarter. American Century Companies Inc. now owns 5,564,318 shares of the company’s stock worth $433,405,000 after purchasing an additional 86,560 shares during the period. Finally, Geode Capital Management LLC increased its stake in shares of Docusign by 0.5% in the fourth quarter. Geode Capital Management LLC now owns 4,084,463 shares of the company’s stock worth $278,665,000 after purchasing an additional 18,873 shares during the period. Institutional investors own 77.64% of the company’s stock.
Key Docusign News
Here are the key news stories impacting Docusign this week:
- Positive Sentiment: Q4 beat — DocuSign reported Q4 revenue and EPS modestly above consensus and reiterated growth guidance, showing continued subscription momentum and giving a near‑term fundamental support for the stock. Proactive: DocuSign beats Q4 estimates
- Positive Sentiment: Large buyback authorized — The board approved a $2.0 billion increase (bringing total authorization to roughly $2.6B), representing a material portion of market cap; buybacks are a direct capital‑allocation tool that can support the share price and signal management confidence. DocuSign press release: buyback
- Neutral Sentiment: Higher trading volume — Volume spiked after the earnings release, which raises short‑term volatility and can amplify both rebounds and selloffs depending on flow. American Banking News: Volume Increase After Earnings
- Neutral Sentiment: Short‑interest reporting appears inconsistent — March short‑interest entries in the feed show anomalous “0”/NaN values, so there’s no clear short‑flow signal from these data points at this time.
- Negative Sentiment: Analyst cuts and cautious notes — Multiple major brokerages trimmed price targets and moved to more cautious ratings (examples include Morgan Stanley, RBC, UBS, JPMorgan, Piper Sandler, Wells Fargo and others), reducing near‑term upside expectations and contributing to selling pressure. American Banking News: Morgan Stanley Lowers Price Target
- Negative Sentiment: Insider sale disclosed — Senior executive Robert Chatwani sold ~16.7k shares (~$803k); while single insider sales can be routine, the filing has weighed on sentiment alongside the analyst downgrades. SEC Form 4: Insider Sale
About Docusign
DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.
DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.
Recommended Stories
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.
